Cargando…

An equitable and accessible vaccine supply chain network in the epidemic outbreak of COVID-19 under uncertainty

Vaccination is one of the most efficient ways to restrict and control the spread of epidemic outbreaks such as COVID-19. Due to the limited COVID-19 vaccine supply, an equitable and accessible plan should be prepared to cope with. This research focuses on designing a vaccine supply chain while aimin...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiri, Mahdyeh, Ahmadizar, Fardin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171116/
https://www.ncbi.nlm.nih.gov/pubmed/35692508
http://dx.doi.org/10.1007/s12652-022-03865-2
_version_ 1784721592883871744
author Shiri, Mahdyeh
Ahmadizar, Fardin
author_facet Shiri, Mahdyeh
Ahmadizar, Fardin
author_sort Shiri, Mahdyeh
collection PubMed
description Vaccination is one of the most efficient ways to restrict and control the spread of epidemic outbreaks such as COVID-19. Due to the limited COVID-19 vaccine supply, an equitable and accessible plan should be prepared to cope with. This research focuses on designing a vaccine supply chain while aiming to achieve an equitable and accessible network. We present a novel mathematical formulation that helps to optimize vaccine distribution to inoculate people with various priority levels to achieve an equitable plan. The transshipment strategy is also incorporated into the model to enhance the accessibility of COVID-19 vaccine types between health facilities. The nature of COVID-19 is dynamic over time due to mutations, and the protection level of each vaccine type against this disease is not exact. Besides, complete information about the demand for different vaccine types is not available. Hence, we use Multi-Stage Stochastic Programming as a reliable strategy that is organized to manage stochastic data in a dynamic environment for the first time in the vaccine supply chain network. The scenarios in this approach are generated using a Monte Carlo simulation method, and then a forward scenario reduction technique is conducted to construct a suitable scenario tree. The practicality and capability of the model are shown in a real-life case of Iran. The results show that the performance of the Multi-Stage Stochastic Programming is significantly improved compared with the two-stage stochastic programming regarding the total cost of the vaccine supply chain and the number of the shortage units.
format Online
Article
Text
id pubmed-9171116
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-91711162022-06-08 An equitable and accessible vaccine supply chain network in the epidemic outbreak of COVID-19 under uncertainty Shiri, Mahdyeh Ahmadizar, Fardin J Ambient Intell Humaniz Comput Original Research Vaccination is one of the most efficient ways to restrict and control the spread of epidemic outbreaks such as COVID-19. Due to the limited COVID-19 vaccine supply, an equitable and accessible plan should be prepared to cope with. This research focuses on designing a vaccine supply chain while aiming to achieve an equitable and accessible network. We present a novel mathematical formulation that helps to optimize vaccine distribution to inoculate people with various priority levels to achieve an equitable plan. The transshipment strategy is also incorporated into the model to enhance the accessibility of COVID-19 vaccine types between health facilities. The nature of COVID-19 is dynamic over time due to mutations, and the protection level of each vaccine type against this disease is not exact. Besides, complete information about the demand for different vaccine types is not available. Hence, we use Multi-Stage Stochastic Programming as a reliable strategy that is organized to manage stochastic data in a dynamic environment for the first time in the vaccine supply chain network. The scenarios in this approach are generated using a Monte Carlo simulation method, and then a forward scenario reduction technique is conducted to construct a suitable scenario tree. The practicality and capability of the model are shown in a real-life case of Iran. The results show that the performance of the Multi-Stage Stochastic Programming is significantly improved compared with the two-stage stochastic programming regarding the total cost of the vaccine supply chain and the number of the shortage units. Springer Berlin Heidelberg 2022-06-07 /pmc/articles/PMC9171116/ /pubmed/35692508 http://dx.doi.org/10.1007/s12652-022-03865-2 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Research
Shiri, Mahdyeh
Ahmadizar, Fardin
An equitable and accessible vaccine supply chain network in the epidemic outbreak of COVID-19 under uncertainty
title An equitable and accessible vaccine supply chain network in the epidemic outbreak of COVID-19 under uncertainty
title_full An equitable and accessible vaccine supply chain network in the epidemic outbreak of COVID-19 under uncertainty
title_fullStr An equitable and accessible vaccine supply chain network in the epidemic outbreak of COVID-19 under uncertainty
title_full_unstemmed An equitable and accessible vaccine supply chain network in the epidemic outbreak of COVID-19 under uncertainty
title_short An equitable and accessible vaccine supply chain network in the epidemic outbreak of COVID-19 under uncertainty
title_sort equitable and accessible vaccine supply chain network in the epidemic outbreak of covid-19 under uncertainty
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171116/
https://www.ncbi.nlm.nih.gov/pubmed/35692508
http://dx.doi.org/10.1007/s12652-022-03865-2
work_keys_str_mv AT shirimahdyeh anequitableandaccessiblevaccinesupplychainnetworkintheepidemicoutbreakofcovid19underuncertainty
AT ahmadizarfardin anequitableandaccessiblevaccinesupplychainnetworkintheepidemicoutbreakofcovid19underuncertainty
AT shirimahdyeh equitableandaccessiblevaccinesupplychainnetworkintheepidemicoutbreakofcovid19underuncertainty
AT ahmadizarfardin equitableandaccessiblevaccinesupplychainnetworkintheepidemicoutbreakofcovid19underuncertainty